The US FDA plans to shorten drug testing periods by monitoring clinical trials in real time, a move aimed at accelerating the development of new medicines.
The U.S. Food and Drug Administration plans to cut the time it takes drug companies to test new medicines by increasing oversight of clinical trials as they are conducted.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
Open map near United States
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
More story pages
Ebola vaccine for current Bundibugyo strain to take 6-9 months, says WHO. 139 deaths, 600 suspected cases.
Vaccine for current Ebola strain Bundibugyo to take 6-9 months, says WHO's Dr. Murt. 139 deaths, 600 suspected cases.
US absent from Ebola emergency talks in Geneva
US absent from Ebola emergency talks in Geneva
Russia's consumer safety agency seeks info on mass tourist poisoning in Egypt's Xanadu Makadi Bay hotel
Russian health authority requests information on mass poisoning of Russian tourists in Egypt
U.S. asks Germany to help bring family of American Ebola patient from DRC
U.S. requests Germany's assistance to transport family members of an American Ebola patient from DRC.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.